These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Therapy monitoring in cardiac arrhythmias: guidelines for evaluation of anti-arrhythmia effects].
    Author: Hief C, Podczeck A, Frohner K, Nürnberg M, Kaltenbrunner W, Steinbach K.
    Journal: Wien Med Wochenschr; 1994; 144(14-15):379-81. PubMed ID: 7825329.
    Abstract:
    The incidence of avoidable or unavoidable, cardial and extracardial side effects is a risk in the drug treatment of supraventricular and ventricular tachyarrhythmias. Therefore the indication of antiarrhythmic drug therapy has to be considered critically. The patient has to be controlled close-meshed, especially at the beginning of the drug treatment. In patients with life threatening ventricular tachyarrhythmias, which can not be suppressed by drug therapy, nonpharmacological therapy--implantable cardioverter/defibrillator, catheterablation and heart-transplantation--has to be discussed.
    [Abstract] [Full Text] [Related] [New Search]